Nicotine and Parkinson's disease: implications for therapy

Quik, Maryka, O'Leary, Kathryn, Tanner, Caroline M.·2008·Movement Disorders
DOI 10.1002/mds.21900

Cited by (154)

Items 101–154 of 154

  1. Dopaminergic Neuron‐Specific Tfam Knockout Links Inter‐Organelle Miscommunication to Early‐Onset Parkinsonism
    Weiyan Shen, Mengling Zheng, Yanlin Zhao, Feitao Ni, Xudong Zhu · 2025 · The FASEB Journal
  2. Exercise Strategies for Parkinson Disease Management
    Spencer Ingoglia, Barbara Sue Graves · 2025 · Strength and conditioning journal
  3. Nanotherapeutics a promising approach for treatment of Parkinson’s disease
    Chhavi Bhalothia, Girima Nagda · 2022 · Materials Today Proceedings
  4. Cortico-Striatal, Cognitive-Motor Interactions Underlying Complex Movement Control Deficits
    Aaron J. Kucinski, Martin F. Sarter · 2016 · Innovations in cognitive neuroscience
  5. Nicotine: A Possible Neuroprotector in Brain Disorders
    Karim A. Alkadhi, Samina Salim, Karem Hasan Alzoubi · 2025 · Springer eBooks
  6. Shared pathogenic mechanisms of Parkinson's disease and ulcerative colitis: α7 nicotinic acetylcholine receptor as a potential therapeutic target
    Yingyan Li, Yuhan Gu, Jun‐Xu Li, Fanglin Liu, Huan Chen, Hongwei Hou, Qingyuan Hu · 2025 · International Journal of Biological Macromolecules
  7. Epidemiology
    Raymond Y. Lo, Caroline M. Tanner · 2013 · Informa Healthcare eBooks
  8. Machine Learning Neuroprotective Strategy Reveals a Unique Set of Parkinson Therapeutic Nicotine Analogs
    Felipe Rojas-Rodríguez, Carlos Morantes, Andrés Mauricio Pinzón, George Emilio Barreto, Ricardo Cabezas, Leonardo Mariño‐Ramírez, Janneth González · 2020 · The Open Bioinformatics Journal
  9. Use of tobacco purge in a therapeutic community for the treatment of substance use disorders
    Tereza Rumlerová, Eric Kube, Nahuel Simonet, Fabio Friso, Matteo Politi · 2022 · Anthropology of Consciousness
  10. Exploring the Neuroprotective Effects of Nicotine Against MPTP-Induced Neuronal Damage in Mice: Insights into Antioxidant System
    Nikoloz Zhgenti, Otar Bibilashvili, George Burjanadze, Mariam Shengelia, Nana Koshoridze · 2023 · International Journal of Biochemistry and Biophysics
  11. Protective and Risk Factors in Multiple Sclerosis
    Hosein Nouri, Homayoun Tabesh, Masih Saboori, Karim Sohrabi, Foad Mirhosseini, Zahra Hosseinzadeh Anvar, Mostafa Sharifkhah, Saman Hosseinzadeh Anvar, Vahid Shaygannejad · 2019 · International Journal of Medical Reviews
  12. Mendelian randomization and Parkinson’s disease
    Arinola O. Sanyaolu, Wael Mohamed, Mary B. Makarious, Joanne L. August, Mariam Kekenadze, Karl Heilbron, María Teresa Periñán, Alastair John Noyce, Sara Bandrés‐Ciga · 2024 · Elsevier eBooks
  13. Insights into Crystallization of Neuronal Nicotinic α4β2 Receptor in Polarized Lipid Matrices
    Juan C. Villalobos‐Santos, Mallerie Carrasquillo-Rivera, Josué A. Rodríguez-Cordero, Orestes Quesada, Jose Antonio Lasalde‐Dominicci · 2024 · Crystals
  14. The effects of nicotine on Parkinson's disease: A systematic review and meta-analysis of experimental evidence
    Gudisa Bereda, Javed Ahamad · 2026 · IBRO Neuroscience Reports
  15. Adult-administered chronic nicotine remodels nigral dopaminergic and pedunculopontine cholinergic physiology
    Rita Yu-Tzu Chen, Hassan Hosseini, Skylar Hall, Shirley Q Zhang, Rebekah C. Evans · 2026 · Neuropharmacology
  16. Association Between Lifetime Cigarette Smoking and Lewy Body Accumulation
    J.P. Blass · 2010 · Yearbook of Neurology and Neurosurgery
  17. Anticholinergic agents in the management of Parkinson's disease
    Juan C. Giugni, Ramon Rodriguez-Cruz · 2016 · Cambridge University Press eBooks
  18. Parkinson’s Disease: Possible Mechanisms for Nutritional Approaches
    Christine E. Cherpak-Castagna, Sherryl J. Van Lare · 2020 · Journal of Restorative Medicine
  19. A review of the primary nutritional and environmental factors associated with Parkinson’s disease
    Eleanor Considine, Lucy Yin, Mitra J. Z. Hartmann · 2021 · Journal of Student Research
  20. Effects of nicotine on catecholaminergic neurotransmission in a premotor stage model of Parkinson’s disease
    Cristina Cosi, Agnès L. Auclair, Véronique Ravailhe, N. Malfetes, Véronique Nguyen · 2025 · Academia Biology
  21. Nicotinic Receptors in Brain Diseases
    Jerry A. Stitzel · 2010 · Advances in neurobiology
  22. Parkinson’s disease: will therapy move beyond dopaminergic medication?
    Lívia Dézsi, László Vécsei · 2011 · Clinical Investigation
  23. Pharmacologic Management of Dopaminergic‐Induced Dyskinesias in Parkinson’s Disease
    Mildred D. Gottwald, Michael J. Aminoff · 2013 · Royal Society of Chemistry eBooks
  24. Cigarette Smoking, nicotine and Parkinson’s disease: Controversies in clinical trials data and medical practice.
    A.A. Kesoyan., N.L. Arakelyan, D.A. Aloyan, A.A. Karapetyan, Hovhannes M. Manvelyan · 2022 · THE NEW ARMENIAN MEDICAL JOURNAL
  25. Innovative MRT-Kontraste zur in-vivo-Differenzierung von Patienten mit typischem idiopathischen Parkinson und atypischen Parkinsonsyndromen
    Pia Marie Pantel · 2013
  26. Novel computational deep learning strategy for neuroprotection identification reveals unique set of nicotine analogs as potential therapeutic compounds against Parkinson’s disease
    Felipe Rojas-Rodríguez, Carlos Morantes, Andrés Mauricio Pinzón, George Emilio Barreto, Ricardo Cabezas, Leonardo Mariño‐Ramírez, Janneth González · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Nicotinic Agonists and Antagonists
    Hans Rollema, Daniel Bertrand, Raymond S Hurst · 2015 · Springer eBooks
  28. MPTP
    J. William Langston, Ian Irwin · 2010 · Elsevier eBooks
  29. Nicotinic Agonists and Antagonists
    Hans Rollema, Daniel Bertrand, Raymond S Hurst · 2010 · Springer eBooks
  30. On the influence of dopamine-related genetic variation on dopamine-related disorders
    Olle Bergman · 2009 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  31. 새로운 항우울제의 부작용과 약물학적 처치
    이경규 · 2014 · 대한정신약물학회지
  32. CholinergicModulationofLocomotionandStriatal DopamineReleaseIsMediatedby64*Nicotinic AcetylcholineReceptors
    Ryan M. Drenan, Natalie E. Patzlaff, J. MichaelMcIntosh · 2010
  33. Neuroprotektion durch BAG1 in Modellen des idiopathischen Parkinson-Syndroms
    Anja Friederike Baumann · 2010
  34. Adverse Effects and Pharmacological Management of Newer Antidepressants - Focusing on Common but Under-Recognized Adverse Effect -
    Kyung Kyu Lee · 2014 · 대한정신약물학회지
  35. The Pharmacological Basis for Parkinson's Disease Treatment
    2016 · Cambridge University Press eBooks
  36. Cyclosomatostatin-Induced Catalepsy in the Aged Wistar Rats: Inhibition by Nicotine
    Ilya D. Ionova, Irina I. Pushinskaya · 2017 · Avicenna Journal of Neuro Psych Physiology
  37. Der Einfluss von humanem α-Synuclein-Wildtyp und der Mutanten A30P und A53T auf die Autophagie und den Transport synaptischer Vesikel in primären Mittelhirnneuronen der Ratte
    Florian Bitow · 2020
  38. Epidemiology
    Raymond Y. Lo, Caroline M. Tanner · 2013 · Neurological disease and therapy
  39. Nicotine
    Erika B. Litvin, Joseph W. Ditre, Bryan W. Heckman, Thomas Henry Brandon · 2012 · Springer eBooks
  40. ՊԱՐԿԻՆՍՈՆԻ ՀԻՎԱՆԴՈՒԹՅԱՄԲ ԲՈՒԺԱՌՈՒՆԵՐԻ ՇԱՐԺՈՂԱԿԱՆ ԽԱՆԳԱՐՈՒՄՆԵՐԻ ԽՈՐԱՑՈՒՄԸ` ՊԱՅՄԱՆԱՎՈՐՎԱԾ ՆԻԿՈՏԻՆԻ (ԾԽԱԽՈՏԻ) ԸՆԴՈՒՆՄԱՆ ԴԱԴԱՐԵՑՄԱՄԲ
    N.L. Arakelyan, A.A. Kesoyan., D.A. Aloyan, Hovhannes M. Manvelyan · 2023 · MEDICINE SCIENCE AND EDUCATION
  41. Associations of the Life’s Essential 8 with Parkinson’s disease: a population-based study
    Chenguang Zhou, Oumei Cheng · 2025 · Frontiers in Aging Neuroscience
  42. Adiphenine Alleviates Impulsive‐Like Behaviors in Aged Mice by Inhibiting Nicotinic Acetylcholine Receptors
    Heng‐Yue Peng, Yi‐Long Gao, Luying Wang, Jin‐Meng Lv, Hui‐Tao Miao, Liang‐Ya Li, Rong‐Xin Song, Tingting Zhou, Ping An, Xiaochun Zhao et al. · 2025 · Journal of Neurochemistry
  43. Investigating the Potential Roles of Environmental Exposures on the Pathology of Amyotrophic Lateral Sclerosis by Overlap Analysis
    Nazli Sila Kara, Ozan Özışık, Anaı̈s Baudot, Lenka LS Slachtova · 2025 · Neurotoxicity Research
  44. From cigarettes to compulsions: a longitudinal study in de novo Parkinson's disease
    Matilde Massara, Luca Vedovelli, Fabio Masina, Nicky Edelstyn, Patrizia Silvia Bisiacchi, Elisa Di Rosa · 2025 · Frontiers in Psychology
  45. Chronic nicotine reduces nigral dopaminergic activity and remodels pedunculopontine cholinergic subpopulations
    Rita Yu-Tzu Chen, Hassan Hosseini, Skylar Hall, S. Zhang, Rebekah C. Evans · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Efficient asymmetric hydrogenation of 2-pyridyl cyclic imines enabled by a novel hybrid diphosphine ligand
    Bing Jiao, Yi Yu, Wendian Li, Jichao Wan, Yiyan Zhang, Shuang Deng, Jian Zhang, Xiaotian Qi, Shengli Chen, Hui Lv · 2026 · Chinese Chemical Letters
  47. Impact moléculaire de l’exposition subchronique par voie orale à un pesticide, le paraquat, dans un modèle murin transgénique de synucléinopathie humaine : implication du système nerveux entérique
    Nicolas Naudet · 2017 · theses.fr (ABES)
  48. Differential Proteomic Response to Smoking Exposure Underlies Reduced Parkinson’s Disease Risk in Women
    Steven P. Lehrer, Peter H. Rheinstein · 2026 · Cureus
  49. Knowledge and Misconceptions About Parkinson’s Disease in Lebanon: A Cross‐Sectional Survey
    Noura El-Loubani, Hanan Hijazi, Sarah Mawed, Layal El Bayda, Rabih Roufayel, Hervé Kovacic, Ziad Fajloun, Jeanne d’arc Bacha · 2026 · Parkinson s Disease
  50. Body Temperature and Discriminative Stimulus Effects of Nicotine and Menthol Aerosols in Male Rats: Role of α4β2 Nicotinic Acetylcholine Receptors
    Tae In Eom, Pill-Kyu Jang, Jiyun Nam, Suji Kim, Bong Hyo Lee, Suchan Chang, Hye Jin, Jaesuk Yun, Chae Ha Yang, Sooyeun Lee et al. · 2026 · ACS Chemical Neuroscience
  51. Nicotine modulates α7nAChR associated ceramide-mitochondrial stress responses in Parkinsonian models
    Gaoge Wang, Zhen Ni, Jingzheng Zhang, Qian Li, Yunfu Tan, Hao Yu, Er Hong, Chunmei Guang, Shu Wang, Huan Chen et al. · 2026 · Free Radical Biology and Medicine
  52. A multi-omics insight into the sex-specific burden of tobacco-associated neurodegeneration: trends, projections, and mechanistic clues from the TH gene
    Ying Xu, Qinwen Wang, Hongyu Tang, G Y Ji, Runjuan Yang, Dongying Wu, Yaxing Gui · 2026 · Neurological Sciences
  53. Spatial Lipidomics and Transcriptomics Reveal Nicotine-Mediated Restoration of Lipid Homeostasis in Parkinson’s Disease
    Yingyan Li, Lili Cui, Lingxiao Song, Shulei Han, Yibo Chen, Zhen Ni, Yaning Fu, Hongjuan Wang, Yushan Tian, Xiao Li et al. · 2026 · Journal of Lipid Research
  54. Nicotinic receptor in dopamine neurons mediates learned odor choice
    Nobuhiro Yamagata, Nobuhiro Takahashi, Rino Ichikawa, Eru Wada, Momo Murakami, Ayako Abe, Mai Kanno, Toshiharu Ichinose, N. Katayama, Hiromu Tanimoto · 2026 · PLoS Genetics